top of page
amlm3-c-01_edited.jpg

VANEKER CLINICAL RESEARCH SUPPORT

WELCOME

Vaneker Clinical Research Support (CRS) has a broad experience in international Clinical Research:

  • This varies from sponsor to investigator initiated trials, pharma, biotech and devices, ranging from phase I to IV

  • Specialized in the area of Oncology/Haematological Malignancies, but also experienced in several other areas


If you have any questions concerning the information on this website, please contact us.

Yours sincerely,

Vaneker Clinical Research Support 

irma@vanekerCRS.com or +31 (0) 6 421 422 32

Home: Welkom

ABOUT

Vaneker Clinical Research Support

My name is Irma C.V. Vaneker.

I have a long history of work experience, after obtaining my diploma of Microbiology Analyst in 1996, I worked several years at the Laboratory of Microbiology in Enschede.

After surviving Leukemia in 1998 I started working for the Ethics Committee in Enschede as a “proefpersonenlid”.

In 2008 I started as a CRA in Clinical Research at a Pharmaceutical company. Thereafter I have worked in different roles within Clinical Research as an International sr CRA (Trainer, Site manager, Lead-CRA) with different Pharmaceutical Companies and CROs and within diverse therapeutic areas.

In 2020 I started my own company as Freelance CRA to find a more work-life balance and spend more quality time on my private life.


I am a collaborative team player, closely connected to clinical site staff and at the same time a partner with the Sponsor or CRO. Consistently exceed expectations and provide highest delivery of quality service.


You will find in me a no-nonsense, committed, approachable, analytical, pragmatic and solution seeking partner.

IMG-20200915-WA0011_edited_edited_edited_edited.jpg
Home: Wie wij zijn

SUPPORT

Vaneker Clinical Research Support

400JpgdpiLogo_edited_edited.jpg
  • Feasibility

  • Site selection

  • Pre-study visits

  • Initiation visits

  • Monitoring visits (remote ARBM/on-site)

  • Drug accountability

  • Pharmacovigilance and Safety

  • Set up and maintenance of the study file

  • Close-out visits

400JpgdpiLogo_edited_edited.jpg
  • Site Management

  • ​Co-monitoring and training visits

  • Review monitoring visits

  • Writing SOPs, Monitoring Plans

  • Creation of other monitoring documents and tools

  • Central and local IEC (METC) submission

  • Writing of (country specific) patient information and informed consent

400JpgdpiLogo_edited_edited.jpg
  • Contract negotiation with sites and/or vendors

  • Development patient recruitment plans

  • Organization of start-up meetings

  • Audit preparation

  • GCP training, including European clinical trial directive and Dutch legislation

  • SOP training

  • Coaching

Home: Wat we doen

EXPERIENCE

Therapeutic Indications:

  • Early Clinical Development (Phase I): Oncology – Solid Tumors, Haematological Malignancies

  • Phase II-III:

    • Oncology/Hematology – Leukemias and Lymphomas

    • Solid Tumors

    • Antibacterial Vaccine (FDA approval study)

    • Immunization Trial in Adults

    • Pharmacokinetics of Anticoagulant Therapy, Influenza Vaccine, Hemophilia, Cardiovascular Device

    • Immune Mediated Inflammatory Diseases, CardioMetabolic and Infectious Diseases, Neurology, Dermatology

    • Immunology COVID-19 related severe pneumonia

  • Phase IV: Glaucoma Medical Device

  • Countries: The Netherlands, Belgium, Luxemburg, Germany, UK and US

  • Lead-CRA: The Netherlands, US and Germany

  • Language Capabilities: Dutch, English and German

Home: Tekst
_edited_edited.jpg

"As an experience expert I know what it is to be a cancer patient, this makes me even more involved in my work as a Clinical Research Professional"

Irma C.V. Vaneker

Home: Citaat

CONTACT

Would you like to obtain more information about our services, please contact us at irma@vanekerCRS.com or +31 (0) 6 421 422 32

+31 (0) 6 421 422 32

KvK 80716571 | BTW-ID NL003484000B02

  • LinkedIn
Home: Contact
bottom of page